ATE16489T1 - Aroylimidazolone. - Google Patents

Aroylimidazolone.

Info

Publication number
ATE16489T1
ATE16489T1 AT82101706T AT82101706T ATE16489T1 AT E16489 T1 ATE16489 T1 AT E16489T1 AT 82101706 T AT82101706 T AT 82101706T AT 82101706 T AT82101706 T AT 82101706T AT E16489 T1 ATE16489 T1 AT E16489T1
Authority
AT
Austria
Prior art keywords
aroylimidazolone
aroylimidazole
cardiotonics
ones
acid
Prior art date
Application number
AT82101706T
Other languages
English (en)
Inventor
Richard C Dage
Richard A Schnettler
Frank P Palopoli
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE16489T1 publication Critical patent/ATE16489T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Luminescent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT82101706T 1981-03-05 1982-03-04 Aroylimidazolone. ATE16489T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use
EP82101706A EP0059948B1 (de) 1981-03-05 1982-03-04 Aroylimidazolone

Publications (1)

Publication Number Publication Date
ATE16489T1 true ATE16489T1 (de) 1985-11-15

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82101706T ATE16489T1 (de) 1981-03-05 1982-03-04 Aroylimidazolone.

Country Status (18)

Country Link
US (1) US4405628A (de)
EP (1) EP0059948B1 (de)
KR (1) KR890000765B1 (de)
AT (1) ATE16489T1 (de)
AU (1) AU557590B2 (de)
CA (1) CA1190550A (de)
DE (1) DE3267352D1 (de)
DK (1) DK168627B1 (de)
ES (2) ES510087A0 (de)
GB (1) GB2096600B (de)
GR (1) GR76518B (de)
HK (1) HK61686A (de)
IE (1) IE52387B1 (de)
IL (1) IL65137A (de)
MY (1) MY8600700A (de)
NO (1) NO157175C (de)
NZ (1) NZ199885A (de)
PH (1) PH18345A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
CA1262732C (en) * 1984-07-30 1989-11-07 PREPARATION OF 1,3-DIHYDRO-4-PYRIDOYL-2H-IMIDAZOL-2-ONES
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
EP0536279A1 (de) * 1990-06-29 1993-04-14 The Upjohn Company Substituierte 1-(alkoxyphenyl)piperazin mit wirkung auf das zentrale nervensystem und antihypertensiver aktivität
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (de) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (de) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylat-cyclase-rezeptoragonist sp-333 zur verwendung in der darmreinigung
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
IL65137A0 (en) 1982-05-31
AU557590B2 (en) 1986-12-24
DK95482A (da) 1982-09-06
NO820686L (no) 1982-09-06
DK168627B1 (da) 1994-05-09
NZ199885A (en) 1985-04-30
IE52387B1 (en) 1987-10-14
CA1190550A (en) 1985-07-16
HK61686A (en) 1986-08-29
KR830009046A (ko) 1983-12-17
PH18345A (en) 1985-06-05
IL65137A (en) 1987-02-27
ES519254A0 (es) 1984-03-01
ES8305352A1 (es) 1983-04-16
AU8103782A (en) 1982-09-09
US4405628A (en) 1983-09-20
NO157175B (no) 1987-10-26
NO157175C (no) 1988-02-03
EP0059948A1 (de) 1982-09-15
GB2096600B (en) 1985-06-05
ES8402827A1 (es) 1984-03-01
KR890000765B1 (ko) 1989-04-05
EP0059948B1 (de) 1985-11-13
GR76518B (de) 1984-08-10
MY8600700A (en) 1986-12-31
ES510087A0 (es) 1983-04-16
DE3267352D1 (en) 1985-12-19
GB2096600A (en) 1982-10-20
IE820491L (en) 1982-09-05

Similar Documents

Publication Publication Date Title
ES8305352A1 (es) Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
IL66256A (en) Water containing compositions comprising alkali metal salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3670310D1 (de) Elektrochemische behandlung von ligninen.
ATE7387T1 (de) Herstellung des calciumsalzes von alpha-hydroxy- gamma-methylmercaptobuttersaeure.
ATE17719T1 (de) Schwefel-substituierte phenoxypyridine mit antiviraler aktivitaet.
DK540586D0 (da) Cardiotonisk virksomme thiazoloner
ATE9156T1 (de) Therapeutische zusammenstellungen von imidazolpyridinen.
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them
ATE79615T1 (de) Cardiotonische phenyloxazolone.
IT1221010B (it) Impiego di chinoloni nel trattamento di malattie cardiache
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina
ES8505351A1 (es) Un procedimiento para preparar nuevas aroilimidazolonas
AR247730A1 (es) Derivados del acido 2, 2-dimetil-ciclopropanocarboxilico y composiciones insecticidas y acaricidas que los contienen, su preparacion, materias primas y procedimiento para obtenerlas
IT1137558B (it) Procedimento per produrre trialogenuri di titanio riducendo teraalogenuri di titanio
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
IT8320239A0 (it) Derivato del tetraidrotiofenone attivo nelle affezioni broncopolmonari.
ATE51899T1 (de) Elektrochemische behandlung von ligninen.
ATE75617T1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.
IT8322047A0 (it) Composizione per la stimolazione della tricogenesi.
ATE76299T1 (de) Wiederherstellung von gewebe bei tieren.